Pyxis Oncology Inc. (PYXS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.45
0.01 (0.69%)
At close: Jan 15, 2025, 2:41 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.00M | 1.84M | 1.25M | 444.00K | n/a |
Gross Profit | -2.00M | -1.84M | -1.25M | -444.00K | n/a |
Operating Income | -82.20M | -123.48M | -69.72M | -12.89M | -2.88M |
Interest Income | 6.63M | 2.76M | 23.00K | 66.00K | 107.00K |
Pretax Income | -73.79M | -120.72M | -75.97M | -12.83M | -2.77M |
Net Income | -73.79M | -117.95M | -81.54M | -12.76M | -2.67M |
Selling & General & Admin | 32.61M | 37.35M | 18.66M | 3.85M | 1.66M |
Research & Development | 47.89M | 86.13M | 51.05M | 9.05M | 1.22M |
Other Expenses | n/a | n/a | 181.00K | n/a | n/a |
Operating Expenses | 82.20M | 123.48M | 69.72M | 12.89M | 2.88M |
Interest Expense | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 82.20M | 123.48M | 69.72M | 12.89M | 2.88M |
Income Tax | n/a | -2.76M | 5.56M | -66.00K | -107.00K |
Shares Outstanding (Basic) | 39.90M | 33.03M | 32.22M | 34.31M | 34.31M |
Shares Outstanding (Diluted) | 39.90M | 33.03M | 32.22M | 34.31M | 34.31M |
EPS (Basic) | -1.85 | -3.57 | -2.53 | -0.37 | -0.08 |
EPS (Diluted) | -1.85 | -3.57 | -2.53 | -0.37 | -0.08 |
EBITDA | -78.49M | -122.77M | -69.07M | -12.43M | n/a |
Depreciation & Amortization | 2.00M | 1.84M | 1.25M | 444.00K | 2.88M |